Loading organizations...
Key people at NeuX Capital.
NeuX Capital operates as an early-stage incubator platform, specializing in the convergence of intelligence and life sciences. The firm actively identifies and cultivates innovative companies developing cross-technology solutions in these sectors, providing essential support to nascent ventures from concept to market application.
Founded in 2021 and based in Shanghai, China, NeuX Capital lists Xu Jing as a founding partner. The firm's inception reflects an insight into significant opportunities at the intersection of artificial intelligence and biological research, leveraging early-stage investments to bridge these merging technological and scientific domains.
NeuX Capital primarily supports pioneering early-stage companies and entrepreneurs within its chosen intelligence and life science sectors. Its vision aims to foster a dynamic ecosystem of interconnected technological and scientific innovations, facilitating the creation of groundbreaking solutions that will shape future advancements in health, biotechnology, and intelligent systems.
NeuX Capital has 2 tracked investments across 2 companies. The latest tracked deal is $14.0M Seed in Atantares in July 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2023 | Atantares | $14.0M Seed | ALI Health, Asia Green Fund | Qiming Venture Partners, Fosun Health Capital, Jiachen Capital |
| Jun 10, 2022 | Degron Therapeutics | $22.0M Series A | Jing YU | Baidu Ventures, Co WIN Ventures, Dyee Capital |
Key people at NeuX Capital.